Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Association of brain structure and motor function in older persons with multiple sclerosis and healthy controls: A cross-sectional study.
Increased functional network connectivity following cognitive rehabilitation in progressive multiple sclerosis with moderate to severe disabilty: findings from the CogEx study.
Expanding Spectrum of FIG4-Related Neurological Disorders of Lysosomal Homeostasis: Case Report and Overview of the Potential Genotype-Phenotype Correlations.
Viral associations in multiple sclerosis: pathogenetic mechanisms and therapeutic implications.
Analytical and Clinical Validity of a High-Throughput, Fully Automated Immunoassay for Plasma Neurofilament Light Chain.
Lymphopenia predicts infectious complications after alemtuzumab therapy in multiple sclerosis: Real-world experience from a Brazilian cohort.
Recent Advances in Imaging of Demyelinating and Dysmyelinating White Matter Lesions.
[Moxibustion promotes hematoma clearance in rats with intracerebral hemorrhage by up-regulating the expressions of PPARγ/CD36 and M2 phenotype polarization of microglia].
Mesenchymal stromal/stem cell-derived extracellular vesicles in brain disorders: mechanisms of repair and recovery.
Association Between Multiple Sclerosis Severity and Functional Variants in Key Antioxidant Defense and Ferroptosis-Related Genes.
Role of sirtuin 2 in the brain is cell-type and context-dependent: Implications for therapeutic targeting.
A Structured Aerobic Exercise Program Increases Physical Activity in People With Parkinson's Disease: A Secondary Analysis of the CYCLE-II Trial.
Emotional Abuse and Psychological Distress in Individuals with Multiple Sclerosis: The Mediation Role of Internalized Shame and Chronic Illness Stigma.
Maintenance intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy: trends from an Australian tertiary centre.
Neurodevelopmental Consequences Induced by Early-Life Lead Exposure Through Disruption of Neurotransmitter Pathways and Molecular Mechanisms: A Systematic Review.
T1-weighted/T2-weighted ratio reflects microstructural changes in Alzheimer's disease.
Psychological resilience predicts medication adherence in multiple sclerosis.
Differences in Income Growth Between People With Multiple Sclerosis and Controls: A Norwegian Cohort Study.
Invasive sino-orbital aspergillosis with intracranial extension: a multidisciplinary and ethical dilemma in pursuing aggressive surgery versus palliation.
Exploring causal associations between autoimmune diseases and hearing loss: a mendelian randomization study.
ATM-kinase deficiency triggers early multi-compartment remodeling of the cerebellar microenvironment.
GPIHBP1 on oligodendrocytes binds lipoprotein lipase within the human brain.
Global research landscape of oligodendrocytes in Alzheimer's disease: A bibliometric and knowledge-mapping analysis from 1990 to 2025.
Systematic Reviews and Meta-Analyses of the Use of Tocilizumab in Treating Central Nervous Diseases.
Comparative efficacy of ripertamab, rituximab, and efgartigimod in chronic inflammatory demyelinating polyneuropathy: an exploratory real-world multicenter cohort study.
Pages
« first
‹ previous
…
997
998
999
1000
1001
1002
1003
1004
1005
…
next ›
last »